Statizoid

Health in Mus

270 indicators covering health for Mus.

IndicatorLatest Year10-yr change Rank
Overweight numbers among children under 5 years of age (thousands) 2.9 2024 down 9.4% 1st
Overweight prevalence among children under 5 years of age (%) 4.8% 2024 up 6.7% 1st
Number of deaths among children ages 10 to 14 years 15 2021 down 34.8% 2nd
Adolescent mortality rate 0.9466 2021 down 19.5% 2nd
Proportion of population with primary reliance on clean fuels and 99.0% 2024 up 1.0% 1st
Incidence of tuberculosis 13 2024 down 18.8% 2nd
Number of incident tuberculosis cases 160 2024 down 23.8% 2nd
Deaths due to tuberculosis among HIV-negative people 1.2 2024 down 20.0% 2nd
Number of incident tuberculosis cases 15 2024 down 34.8% 2nd
Number of deaths due to tuberculosis, excluding HIV 15 2024 down 21.1% 1st
Tuberculosis - new and relapse cases 104 2024 down 17.5% 2nd
Tuberculosis treatment coverage 65 2024 up 6.6% 1st
Mean BMI (kg/m²) 25.2 2016 up 1.6% 2nd
Rubella - number of reported cases 0 2025 down 100.0% 1st
Treatment success rate: new TB cases 65 2023 down 26.1% 2nd
Yellow fever - number of reported cases 0 2025 — 1st
Poliomyelitis - number of reported cases 0 2018 — 1st
Mortality rate among children ages 10 to 14 years 0.9742 2020 down 19.3% 2nd
Medical doctors 3,840 2023 up 87.7% 1st
UHC Service Coverage sub-index on noncommunicable diseases 68 2023 up 7.9% 2nd
Stillbirth rate 8.9 2023 down 6.2% 2nd
Mean systolic blood pressure 126.5 2015 up 1.6% 1st
UHC Service Coverage Index 75 2023 up 4.2% 1st
UHC Service Coverage sub-index on service capacity and access 72 2023 down 4.0% 1st
UHC Service Coverage sub-index on reproductive, maternal, newborn and 65 2023 up 8.3% 2nd
UHC Service Coverage sub-index on infectious diseases 96 2023 up 3.2% 1st
Rotavirus vaccines completed dose (RotaC) immunization coverage among 90.0% 2025 up 36.4% 1st
Domestic private health expenditure (PVT-D) as percentage of current 53.7% 2023 down 5.4% 1st
Domestic general government health expenditure (GGHE-D) as percentage 2.5% 2023 up 27.7% 2nd
Domestic general government health expenditure (GGHE-D) as percentage 8.2% 2023 up 2.9% 2nd
Out-of-pocket expenditure as percentage of current health expenditure 45.2% 2023 down 14.9% 1st
Current health expenditure (CHE) as percentage of gross domestic 5.6% 2023 up 20.4% 1st
Domestic general government health expenditure (GGHE-D) as percentage 44.3% 2023 up 6.0% 2nd
External health expenditure (EXT) as percentage of current health 2.0% 2023 up 38.6% 2nd
Domestic general government health expenditure (GGHE-D) per capita in 273.16 2023 up 48.5% 1st
Domestic private health expenditure (PVT-D) per capita in US$ 330.94 2023 up 32.5% 1st
Current health expenditure (CHE) per capita in US$ 616.21 2023 up 40.0% 1st
Mumps - number of reported cases 0 2025 down 100.0% 1st
Estimated number of people (all ages) living with HIV 10,000 2025 unchanged 1st
Prevalence of HIV among adults aged 15 to 49 1.1% 2025 down 8.3% 2nd
Incidence of tuberculosis (per 100 000 population) 2 2023 down 13.0% 2nd
Dentists 414 2022 up 37.5% 1st
Estimated antiretroviral therapy coverage among people living with HIV 36.0% 2025 up 50.0% 2nd
External health expenditure (EXT) per capita in US$ 12.11 2023 up 94.1% 2nd
Congenital Rubella Syndrome - number of reported cases 0 2025 down 100.0% 1st
Nursing and midwifery personnel 4,459 2023 up 12.5% 1st
Nursing personnel 4,459 2023 up 12.5% 1st
Hypertension: effective treatment coverage (controlled hypertension) 35.4% 2019 up 126.9% 1st
Hypertension: diagnosis coverage among adults aged 30-79 with 66.6% 2019 up 22.7% 1st
Hypertension treatment coverage among adults aged 30-79 with 62.2% 2019 up 32.6% 1st
Hypertension among adults aged 30-79 years, prevalence 33.1 2019 down 11.5% 2nd
Raised blood pressure (SBP>=140 OR DBP>=90) 23.72 2019 down 23.9% 2nd
Hypertension effective treatment coverage (controlled hypertension) 34.5% 2019 up 119.7% 1st
Hypertension among adults aged 30-79 years, prevalence, crude 36.7 2019 down 0.5% 2nd
Hypertension treatment coverage among adults aged 30-79 with 60.2% 2019 up 26.7% 1st
Hypertension: diagnosis coverage among adults aged 30-79 with 68.2% 2019 up 26.8% 1st
Raised blood pressure (SBP>=140 OR DBP>=90) 21.67 2019 down 31.3% 2nd
Pneumococcal conjugate second or third-dose vaccines (PCVc) 98.0% 2025 — 1st
Number of new HIV infections 630 2025 down 23.2% 1st
Treatment success rate: previously treated TB cases 0 2022 down 100.0% 2nd